Brian Lian is Chief Executive Officer of Viking Therapeutics, Inc. (VKTX). The company reported total compensation of $21,269,833 for fiscal year 2025.
| Salary | $672,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $17,756,817 |
| Option awards | $2,468,016 |
| Non-equity incentive plan | $373,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $21,269,833 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Viking Therapeutics, Inc. filed April 1, 2026, accession 0001193125-26-137915.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $672,000 | $0 | $17,756,817 | $2,468,016 | $373,000 | $0 | $0 | $21,269,833 |
| FY2024 | Chief Executive Officer | $640,000 | $0 | $8,468,006 | $4,636,800 | $440,000 | $0 | $113,748 | $14,298,554 |
| FY2023 | Chief Executive Officer | $615,000 | $0 | $7,937,803 | $3,703,158 | $372,100 | $0 | $0 | $12,628,061 |
Totals as disclosed in each year's own compensation disclosure for Viking Therapeutics, Inc..
| Peer-group chief executive median | $13,523,993 |
|---|---|
| Difference from that median | $7,745,840 |
| Percentile within the disclosed peer group | 94th |
| Peers with a disclosed figure | 17 |
Medians and percentiles are computed across the peer group Viking Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Brian Lian this page | Chief Executive Officer | $21,269,833 |
| Marianne Mancini | Chief Operating Officer | $5,162,872 |
| Greg Zante | Chief Financial Officer | $5,135,872 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Viking Therapeutics, Inc. compensation brief.
Brian Lian's compensation sits inside Viking Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.